Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about LILLY DRN
Recent news which mentions LILLY DRN
< Previous
1
2
3
Next >
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
February 06, 2025
Tags
US: News
Business
LILLY DRN
From
CNBC.com News
Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars
February 06, 2025
Tags
Business News
Companies
Health & Science
From
CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
February 05, 2025
Tags
Health care industry
Novo Nordisk A/S
LILLY DRN
From
CNBC.com News
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
February 05, 2025
Tags
Biotechnology
Biotech and Pharmaceuticals
Business
From
CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
February 04, 2025
Tags
Biotech and Pharmaceuticals
Science
Social issues
From
CNBC.com News
5 things to know before the stock market opens Monday
February 03, 2025
Tags
Business News
Walt Disney Co
International trade
From
CNBC.com News
Reid Hoffman enters 'wondrous and terrifying' world of health care with latest AI startup
February 02, 2025
Tags
Technology
Breaking News: Technology
AI / Artificial Intelligence
From
CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
January 31, 2025
Tags
Amazon/com Inc
Merck & Co Inc
Pfizer Inc
From
CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
January 28, 2025
Tags
Business News
Novo Nordisk A/S
Companies
From
CNBC.com News
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
January 28, 2025
Tags
Medicaid
Health & Science
Elevance Health Inc
From
CNBC.com News
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
January 26, 2025
Tags
Biotechnology
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
January 21, 2025
Tags
Biotech and Pharmaceuticals
Policy
Davos WEF
From
CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
January 18, 2025
Tags
Hospitals
Cigna Corp
Illumina Inc
From
CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
January 17, 2025
Tags
US: News
Business
Social issues
From
CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
January 15, 2025
Tags
Eisai Co Ltd
US: News
Business
From
CNBC.com News
Jim Cramer says he supports healthcare stocks for their long-term value
January 14, 2025
Tags
stocks
Investment Strategy
LILLY DRN
From
CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
January 14, 2025
Tags
Teladoc Health Inc
Amgen Inc
Dexcom Inc
From
CNBC.com News
Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand
January 14, 2025
Tags
Biotech and Pharmaceuticals
Breaking News: Business
Earnings
From
CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
January 13, 2025
Tags
Novo Nordisk A/S
LILLY DRN
Health care industry
From
CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
January 10, 2025
Tags
LILLY DRN
Novo Nordisk A/S
Labor economy
From
CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
January 08, 2025
Tags
Novo Nordisk A/S
Companies
Business News
From
CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
January 08, 2025
Tags
Merck & Co Inc
Accolade Inc
Pfizer Inc
From
CNBC.com News
Cramer's Lightning Round: Uber is a buy
January 02, 2025
Tags
Business News
PENN Entertainment Inc
Mad Money
From
CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
December 24, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Health & Science
From
CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
December 20, 2024
Tags
Business News
Health care industry
Companies
From
CNBC.com News
5 things to know before the stock market opens Friday
December 20, 2024
Tags
Nike Inc
Markets
LILLY DRN
From
CNBC.com News
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
December 19, 2024
Tags
Breaking News: Business
Pharmaceuticals
Health & Science
From
CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
December 11, 2024
Tags
Health & Science
Social issues
Roche Holding AG
From
CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
December 11, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
Amazon/com Inc
From
CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
December 08, 2024
Tags
Weight management
Novo Nordisk A/S
Hims & Hers Health Inc
From
CNBC.com News
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit